Literature DB >> 9163986

Epidemiology of neurocysticercosis in Brazil.

S Agapejev1.   

Abstract

A revision of literature was done with the objective of tracing an epidemiologic profile of neurocysticercosis (NCC) in Brazil. The prevalence was 0.12-9% in autopsies. The frequency was 0.03-7.5% in clinical series and 0.68-5.2% in seroepidemiological studies. The disease corresponds to 0.08-2.5% of admissions to general hospitals. Patient origin was rural in 30-63% of cases. The most involved age range (64-100%) was 11 to 60 years, with a predominance (22-67%) between 21 and 40 years. The male sex was the most affected (51-80%). In the severe forms there was a predominance of urban origin (53-62%) and of the female sex (53-75%). The period of hospitalization ranges from 1 to 254 days and 33 to 50% of patients suffer 1.7 +/- 1.4 admissions. The clinical picture was variable, with a predominance of epileptic syndrome (22-92%) and intracranial hypertension (19-89%). Psychiatric manifestations were associated in 9-23% of patients. Lethality was 0.29% in terms of all diseases in general and 4.8-25.9% in terms of neurologic diseases. The asymptomatic form was detected in 6% of patients in clinical series and in 48.5% of case from autopsies. The racemose form and ventricular localization also was observed as asymptomatic form. Among the patients with cutaneous cysticercosis 65% of them showed neurologic manifestations.

Entities:  

Mesh:

Year:  1996        PMID: 9163986     DOI: 10.1590/s0036-46651996000300008

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  7 in total

1.  Neurocysticercosis--retrospective study of autopsy reports, a 17-year experience.

Authors:  Sérgio Monteiro de Almeida; Luiz Fernando Bleggi Torres
Journal:  J Community Health       Date:  2011-10

2.  Specific Taenia crassiceps and Taenia solium antigenic peptides for neurocysticercosis immunodiagnosis using serum samples.

Authors:  E C Bueno; A J Vaz; L D Machado; J A Livramento; S R Mielle
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

3.  Serodiagnosis of human cysticercosis by using antigens from vesicular fluid of Taenia crassiceps cysticerci.

Authors:  E C Bueno; M Snege; A J Vaz; P G Leser
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

4.  Detection of Taenia solium antigens and anti-T. solium antibodies in paired serum and cerebrospinal fluid samples from patients with intraparenchymal or extraparenchymal neurocysticercosis.

Authors:  Silvia Rodriguez; Pierre Dorny; Victor C W Tsang; E Javier Pretell; Jef Brandt; Andres G Lescano; Armando E Gonzalez; Robert H Gilman; Hector H Garcia
Journal:  J Infect Dis       Date:  2009-05-01       Impact factor: 5.226

Review 5.  Genetic Diversity of Taenia solium and its Relation to Clinical Presentation of Cysticercosis.

Authors:  Akira Ito; Christine M Budke
Journal:  Yale J Biol Med       Date:  2021-06-30

6.  A rapid slide agglutination test for the diagnosis of neurocysticercosis in the rural health set up.

Authors:  Rakhi Biswas; Subhash Chandra Parija
Journal:  Trop Parasitol       Date:  2011-07

7.  Cognitive and surgical outcome in mesial temporal lobe epilepsy associated with hippocampal sclerosis plus neurocysticercosis: a cohort study.

Authors:  Marino M Bianchin; Tonicarlo R Velasco; Erica R Coimbra; Ana C Gargaro; Sara R Escorsi-Rosset; Lauro Wichert-Ana; Vera C Terra; Veriano Alexandre; David Araujo; Antonio Carlos dos Santos; Regina M F Fernandes; João A Assirati; Carlos G Carlotti; João P Leite; Osvaldo M Takayanagui; Hans J Markowitsch; Américo C Sakamoto
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.